TherapeuticsMD (TXMD) Confirms FDA Approval of ANNOVERA for Birth Control

August 10, 2018 3:06 PM EDT Send to a Friend
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the United States (U.S.) Food and Drug Administration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login